Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06416007

Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

Led by University of Cincinnati · Updated on 2026-05-04

37

Participants Needed

1

Research Sites

147 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this research study is to determine if lattice radiation therapy (LRT) will provide better treatment for bulky (large) tumors than current standard of care radiotherapy.

CONDITIONS

Official Title

Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Solid tumor malignancy with a clinical indication for radiation
  • Patients must have measurable disease
  • Target lesion(s) amenable to lattice therapy plan
  • Target lesion for radiation must be immobilizable during radiotherapy delivery when applicable
  • Age 18 years or older
  • ECOG Performance status 2 or better
  • Life expectancy greater than 3 months
  • Women of child-bearing potential and men must agree to avoid conception by abstinence or birth control prior to and for at least 30 days after lattice therapy
  • Ability to understand and willingness to sign informed consent
Not Eligible

You will not qualify if you...

  • Receiving cytotoxic chemotherapy or radiosensitizing agents within 5 days before or after lattice therapy
  • Hematologic malignancies including lymphoma and leukemia
  • Primary or metastatic central nervous system malignancies
  • History of conditions increasing radiation toxicity
  • Known contraindications to radiation therapy
  • Uncontrolled intercurrent illness
  • Pregnant women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Cincinnati Medical Center

Cincinnati, Ohio, United States, 45219

Actively Recruiting

Loading map...

Research Team

U

UCCC Clinical Trials Office

CONTACT

A

Andrew Frankart, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors | DecenTrialz